{"id":"https://openalex.org/W1976869578","doi":"https://doi.org/10.1055/s-0032-1330033","title":"Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care","display_name":"Safety, Effectiveness and Tolerance of Buprenorphine-Naloxone in the Treatment of Opioid Dependence: Results from a Nationwide Non-Interventional Study in Routine Care","publication_year":2013,"publication_date":"2013-01-04","ids":{"openalex":"https://openalex.org/W1976869578","doi":"https://doi.org/10.1055/s-0032-1330033","mag":"1976869578","pmid":"https://pubmed.ncbi.nlm.nih.gov/23293011"},"language":"en","primary_location":{"id":"doi:10.1055/s-0032-1330033","doi":"https://doi.org/10.1055/s-0032-1330033","is_oa":true,"landing_page_url":"https://doi.org/10.1055/s-0032-1330033","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1330033.pdf","source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1330033.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"S. Apelt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Apelt","raw_affiliation_strings":["Certum Consulting - Scientific Research, Oberbergkirchen, Germany","Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certum Consulting - Scientific Research, Oberbergkirchen, Germany","institution_ids":[]},{"raw_affiliation_string":"Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026643169","display_name":"Norbert Scherbaum","orcid":"https://orcid.org/0000-0003-1759-6990","observed_orcids":["https://orcid.org/0000-0003-1759-6990"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"N. Scherbaum","raw_affiliation_strings":["LVR-Klinikum Essen, Universit\u00e4t Duisburg-Essen, Suchtforschungsgruppe an der Klinik f\u00fcr Psychiatrie und Psychotherapie, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LVR-Klinikum Essen, Universit\u00e4t Duisburg-Essen, Suchtforschungsgruppe an der Klinik f\u00fcr Psychiatrie und Psychotherapie, Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111790053","display_name":"J\u00f6rg G\u00f6lz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. G\u00f6lz","raw_affiliation_strings":["Praxiszentrum Kaiserdamm, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Praxiszentrum Kaiserdamm, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082182568","display_name":"Markus Backmund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Backmund","raw_affiliation_strings":["Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101507538","display_name":"Michael Soyka","orcid":"https://orcid.org/0000-0002-8771-9151","observed_orcids":["https://orcid.org/0000-0002-8771-9151"]},"institutions":[{"id":"https://openalex.org/I4210103212","display_name":"Privatklinik Meiringen","ror":"https://ror.org/00tbqf005","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210103212"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["CH","DE"],"is_corresponding":false,"raw_author_name":"M. Soyka","raw_affiliation_strings":["Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany","Privatklinik Meiringen, Willigen, Meiringen, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Privatklinik Meiringen, Willigen, Meiringen, Switzerland","institution_ids":["https://openalex.org/I4210103212"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8884,"has_fulltext":true,"cited_by_count":33,"citation_normalized_percentile":{"value":0.94729336,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"46","issue":"03","first_page":"94","last_page":"107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine-naloxone","display_name":"buprenorphine/naloxone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6060000061988831},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.8069999814033508},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.7710000276565552},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6779999732971191},{"id":"https://openalex.org/keywords/concomitant-drug-use","display_name":"concomitant drug use","score":0.7319999933242798},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9599999785423279},{"id":"https://openalex.org/keywords/medication-acceptance","display_name":"drug acceptance","score":0.42399999499320984},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.7020000219345093},{"id":"https://openalex.org/keywords/general-practitioners","display_name":"general practitioners","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9353512525558472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8678619861602783},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.8265004754066467},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6187671422958374},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5209659337997437},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.5042740106582642},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4629693031311035},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4445532262325287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2239292860031128},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012647","descriptor_name":"Self-Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016206","descriptor_name":"Databases, Bibliographic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D019370","descriptor_name":"Observation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-0032-1330033","doi":"https://doi.org/10.1055/s-0032-1330033","is_oa":true,"landing_page_url":"https://doi.org/10.1055/s-0032-1330033","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1330033.pdf","source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:23293011","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23293011","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1055/s-0032-1330033","doi":"https://doi.org/10.1055/s-0032-1330033","is_oa":true,"landing_page_url":"https://doi.org/10.1055/s-0032-1330033","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1330033.pdf","source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1976869578.pdf","grobid_xml":"https://content.openalex.org/works/W1976869578.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1201749067","https://openalex.org/W1973170627","https://openalex.org/W1977681341","https://openalex.org/W1986989279","https://openalex.org/W1997125692","https://openalex.org/W1998207473","https://openalex.org/W2006406451","https://openalex.org/W2018017357","https://openalex.org/W2081812523","https://openalex.org/W2097910464","https://openalex.org/W2099536555","https://openalex.org/W2100048597","https://openalex.org/W2112174894","https://openalex.org/W2121538801","https://openalex.org/W2134099955","https://openalex.org/W2147528480","https://openalex.org/W2152947180","https://openalex.org/W2758682213","https://openalex.org/W2949419834","https://openalex.org/W6655147988"],"related_works":["https://openalex.org/W2178765203","https://openalex.org/W2197703284","https://openalex.org/W2954411100","https://openalex.org/W2059202359","https://openalex.org/W2184218697","https://openalex.org/W2080884264","https://openalex.org/W2115867760","https://openalex.org/W3017204259","https://openalex.org/W2621160284","https://openalex.org/W2901162813"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Buprenorphine":[1],"is":[2],"well":[3,227],"known":[4],"in":[5,43,45,74,81,101,107,118,190,218,233,247],"the":[6,30,36,49,52,75,149,186,193,196,208,219],"treatment":[7,76,109,191,201,220,236],"of":[8,39,51,72,77,130,170,195,207,216,221,240,249],"opioid":[9,78,103,222,230],"dependence.":[10,223],"Despite":[11],"a":[12,58],"high":[13,212],"safety":[14,215],"profile":[15],"and":[16,25,35,70,115,134,142,152,168,214,244],"good":[17],"tolerance":[18],"buprenorphine":[19],"has":[20],"been":[21],"subject":[22],"to":[23,63],"misuse":[24,29],"diversion.":[26],"To":[27],"reduce":[28],"antagonist":[31],"naloxone":[32],"was":[33,41,61,94,156,183,226],"added":[34],"4:1":[37],"combination":[38],"buprenorphine-naloxone":[40,73,217],"launched":[42],"Germany":[44],"March":[46],"2007.":[47],"On":[48],"basis":[50],"results":[53],"from":[54,110],"international":[55],"clinical":[56],"trials":[57],"non-interventional":[59,209],"study":[60,93,210],"conducted":[62],"gather":[64],"data":[65,122],"on":[66],"safety,":[67],"effectiveness,":[68],"retention":[69,181],"acceptability":[71],"dependent":[79,104,231],"patients":[80,105,131,188,232],"routine":[82],"care.":[83],"METHODS:":[84],"A":[85],"nationwide":[86],"multicentre":[87],"12-month":[88,180],"prospective,":[89],"non-interventional,":[90],"post-marketing,":[91],"surveillance":[92],"carried":[95],"out":[96],"with":[97,132,140,173,202,237],"12":[98],"assessment":[99],"points":[100],"N=384":[102],"currently":[106],"maintenance":[108],"N=69":[111],"general":[112],"practitioners,":[113],"clinics":[114,117],"outpatient":[116],"Germany.":[119],"RESULTS:":[120],"N=337":[121],"sets":[123],"were":[124,138],"eligible":[125],"for":[126,162],"analysis.":[127],"The":[128,179,205,224],"rates":[129],"serious":[133],"non-serious":[135],"adverse":[136],"events":[137],"low":[139],"1.2%":[141],"17.5%,":[143],"respectively.":[144],"No":[145],"deaths":[146],"occurred":[147],"during":[148],"observational":[150],"period":[151],"only":[153],"one":[154],"hospitalization":[155],"documented.":[157],"Concomitant":[158],"drug":[159,242],"use":[160,243],"decreased":[161],"all":[163],"illicit":[164],"substances.":[165],"Mental":[166],"health":[167],"quality":[169,248],"life":[171],"measured":[172],"standardized":[174],"self-assessment":[175],"questionnaires":[176],"improved":[177],"significantly.":[178],"rate":[182],"57.1%.":[184],"Of":[185],"n=181":[187],"still":[189],"at":[192],"end":[194],"observation":[197],"period,":[198],"96.7%":[199],"continued":[200],"buprenorphine-naloxone.":[203],"CONCLUSION:":[204],"findings":[206],"indicate":[211],"effectiveness":[213],"medication":[225],"accepted":[228],"by":[229],"long-term":[234],"substitution":[235],"substantial":[238],"reductions":[239],"concomitant":[241],"measurable":[245],"improvement":[246],"life.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}